GKOS Glaukos Corporation Net earnings per share (EPS TTM)

Glaukos Corp - graphic logo of issuer GKOS

This annual net income per share chart demonstrates the success of Glaukos Corporation (GKOS) as a flagship in glaucoma microsurgery with robust patent protection. High R&D costs and strict FDA oversight create significant barriers to entry for new players. Revenues are based on the supply of implants and drug delivery systems to clinics. The value of -2.97 captures the magnitude of this parameter.

GKOS Glaukos Medical Net earnings per share for the last four quarters (07/04/2022 - 11/17/2026)

Glaukos Corp. - analytical breakdowns and key metrics (GKOS)

- share price and expert price forecast:
Analysis of all company metrics:glaukos.com - GKOS
Mass-produced product of Glaukos Corp

Net income per share over 12 months measures the actual return of each security, allowing an investor to isolate market volatility from fundamental value via the net income per share over the last four quarters. The current value of -2.97 reflects the financial efficiency of Glaukos Corporation, whose implementation of innovative microstents and pharmaceuticals in ophthalmology establishes an unrivaled standard for glaucoma treatment.

Competitors of Glaukos Corporation (GKOS)

Alcon Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Bausch + Lomb|APLS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months belitebio.com (BLTE)|Earnings per share for the last twelve months ocutx.com|Harrow, Inc. (HROW) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months VRDN (Viridian Therapeutics, Inc.)|Earnings per share for the last twelve months LENZ (LENZ Therapeutics)|Earnings per share for the last twelve months Oculis AG OCS|EyePoint Pharma (EYPT) - Net earnings per one share for the last twelve months|kodiak.com - Net earnings per share (EPS TTM)|ALDX (aldeyra.com) - Earnings per share for the last 12 months|KALA: Net earnings per share (EPS TTM)|Opus Genetics, Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months OKYO|ADVM: Earnings per share for the trailing year|Earnings per share for the last twelve months Outlook Therapeutics Inc (OTLK)|Net earnings per share for the last four quarters Clearside Biomedical|NovaBay Pharmaceuticals - Net earnings per share for the last 12 months|KPRX (Kiora Pharma) - Earnings per one share for the last 12 months|ALIM: Net earnings per share for the last 12 months|EYEN - Net earnings per share (EPS TTM)|GHSI (Guardion Health Science) - Net earnings per share for the last 12 months|ocuphire.com - Earnings per share for the trailing year|OPT (Opthea Ltd) - Net earnings per share (EPS TTM)